Cargando…
Expression of CIB1 correlates with colorectal liver metastases but not with peritoneal carcinomatosis
BACKGROUND: Molecular differences in colorectal cancer (CRC) are associated with the metastatic route. Patient survival is mainly driven by metastatic spread thus it is imperative to understand its key drivers to develop biomarkers for risk stratification, follow-up protocols and personalized therap...
Autores principales: | Jacob, Sven, Bösch, Florian, Schoenberg, Markus B., Pretzsch, Elise, Lampert, Christopher, Haoyu, Ren, Renz, Bernhard W., Michl, Marlies, Kumbrink, Jörg, Kirchner, Thomas, Werner, Jens, Angele, Martin K., Neumann, Jens |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603526/ https://www.ncbi.nlm.nih.gov/pubmed/34794407 http://dx.doi.org/10.1186/s12885-021-08927-w |
Ejemplares similares
-
The association of immunosurveillance and distant metastases in colorectal cancer
por: Jacob, Sven, et al.
Publicado: (2021) -
Olfactomedin 4 associates with expression of differentiation markers but not with properties of cancer stemness, EMT nor metastatic spread in colorectal cancer
por: Jaitner, Stefanie, et al.
Publicado: (2022) -
Biomarker alterations associated with distinct patterns of metastatic spread in colorectal cancer
por: Michl, M., et al.
Publicado: (2020) -
Mechanisms of Metastasis in Colorectal Cancer and Metastatic Organotropism: Hematogenous versus Peritoneal Spread
por: Pretzsch, E., et al.
Publicado: (2019) -
Reduction of peritoneal carcinomatosis by intraperitoneal administration of phospholipids in rats
por: Otto, Jens, et al.
Publicado: (2007)